InterVenn

Biotechnology

South San Francisco, California, United States

United States

InterVenn Biosciences identifies, quantifies, and classifies Glycoproteomic and other PTM signals found in human blood and tissue.

Employee 101 to 250 people

Late Stage Venture stage company

Last raised $201,000,000 in August 2021